NCT07767097

Brief Summary

Acquired idiopathic stiffness (AIS) is a common complication following total knee arthroplasty (TKA). It is caused by excessive scar formation, which leads to pain, loss of motion, and functional impairment. When early noninvasive treatments fail, some patients require more surgery. In these cases, surgeons often use a special type of replacement called a hinged prosthesis, which allows more thorough removal of scar tissue and stiffened ligaments. Unfortunately, even after more surgery, many patients continue to struggle with stiffness, pain, and impaired function. Low-dose irradiation (LDI) is a safe, established therapy for conditions with abnormal scar formation. Its role in the setting of AIS has not been defined. The goal of this study is to compare outcomes of revision TKA with or without the addition of LDI. The primary outcome is range of motion at one year following surgery. Secondary outcomes include patient-reported functional scores, repeat surgeries, and complications like wound breakdown or infection. This project has the potential to address a common, debilitating complication after TKA, improve outcomes, reduce repeat interventions and healthcare costs, and broader implementation and standardization of care.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
29mo left

Started Apr 2026

Typical duration for not_applicable

Geographic Reach
2 countries

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
Apr 2026Jan 2029

Study Start

First participant enrolled

April 1, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 11, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 17, 2026

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2029

Last Updated

August 17, 2026

Status Verified

March 1, 2026

Enrollment Period

2.8 years

First QC Date

August 11, 2026

Last Update Submit

August 11, 2026

Conditions

Keywords

arthrofibrosisstiffnessrevision kneelow dose irradiationhinged knee prosthesis

Outcome Measures

Primary Outcomes (1)

  • Total arc of knee range of motion (ROM)

    Goniometric measurement of total arc of motion (flexion minus extension deficit) performed by treating surgeon at each follow-up visit, per standard clinical protocol.

    Baseline (pre-operative), intraoperative, 2 weeks, 6 weeks, 3 months, and1 year post-operatively.

Secondary Outcomes (8)

  • Oxford Knee Score (OKS)

    Pre-op, 2 weeks, 6 weeks, 3 months, 1 year

  • EQ-5D-5L (health-related quality of life)

    Pre-op, 2 weeks, 6 weeks, 3 months, 1 year

  • Visual Analogue Scale (VAS) - Pain

    Pre-op, 2 weeks, 6 weeks, 3 months, 1 year

  • Patient Satisfaction (numeric rating)

    6 weeks, 3 months, 1 year

  • Wound complications (requiring intervention)

    2 weeks, 6 weeks, 3 months, 1 year

  • +3 more secondary outcomes

Study Arms (2)

Hinged Revision TKA + Low-Dose Irradiation

EXPERIMENTAL

Patients undergo hinged revision total knee arthroplasty (TKA) with a rotating hinge prosthesis, followed by a single session of external beam low-dose irradiation (LDI) delivering 800 cGy to the operative knee on post-operative day 1 (or post-operative day 2 if medically necessary), coordinated with radiation oncology.

Radiation: Low-Dose External Beam IrradiationProcedure: Hinged Revision Total Knee Arthroplasty

Hinged Revision TKA Alone

ACTIVE COMPARATOR

Patients undergo hinged revision total knee arthroplasty (TKA) with a rotating hinge prosthesis and receive standard postoperative care without low-dose irradiation. All perioperative care, rehabilitation, and follow-up protocols are identical to the experimental arm.

Procedure: Hinged Revision Total Knee Arthroplasty

Interventions

A single session of external beam irradiation (800 cGy) delivered to the operative knee on post-operative day 1 (or post-operative day 2 if medically necessary). At Mount Sinai Hospital and Humber River Hospital, LDI is delivered at Princess Margaret Cancer Centre. US sites coordinate through local radiation oncology departments.

Hinged Revision TKA + Low-Dose Irradiation

Full component revision to a rotating hinge knee prosthesis, including synovectomy, posterior capsule debridement, and release of fibrosed collateral ligaments, performed by the treating orthopaedic surgeon at each participating site.

Hinged Revision TKA + Low-Dose IrradiationHinged Revision TKA Alone

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (≥18 years) undergoing revision TKA with a hinged prosthesis for AIS after primary TKA
  • Patient with a ROM arc \<70 degrees or flexion contracture of \>20 degrees without any identifiable cause for stiffness (e.g. component oversizing, malrotation, infection, or periprosthetic fracture).

You may not qualify if:

  • Revision for causes other than AIS (e.g., component malposition, infection, periprosthetic fracture)
  • Prior ipsilateral knee infection
  • Revision to non-hinged prosthesis
  • Medical contraindications to surgery
  • Medical contraindications to irradiation
  • Currently pregnant or planning to become pregnant during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

University of Southern California

Los Angeles, California, 90007, United States

NOT YET RECRUITING

University of Utah

Salt Lake City, Utah, 84112, United States

NOT YET RECRUITING

Humber River Hospital

Toronto, Ontario, M3M 0B2, Canada

NOT YET RECRUITING

Mount Sinai Hospital

Toronto, Ontario, M5G 1X5, Canada

RECRUITING

Related Publications (4)

  • Liow MHL, Flevas DA, Braun S, Nocon A, Lee GC, Sculco PK; TKAF Consortium. Rotating Hinge Revision Total Knee Arthroplasty Provides Greater Arc of Motion Gains for Patients Who Have Severe Arthrofibrosis. J Arthroplasty. 2025 Jan;40(1):198-202. doi: 10.1016/j.arth.2024.06.056. Epub 2024 Aug 9.

    PMID: 39128782BACKGROUND
  • Haffar A, Goh GS, Fillingham YA, Torchia MT, Lonner JH. Treatment of arthrofibrosis and stiffness after total knee arthroplasty: an updated review of the literature. Int Orthop. 2022 Jun;46(6):1253-1279. doi: 10.1007/s00264-022-05344-x. Epub 2022 Mar 18.

    PMID: 35301559BACKGROUND
  • Lex JR, Entezari B, Backstein DJ, Wolfstadt JI. Reliable Outcomes Provided by a Rotating Hinge Knee Arthroplasty for Patients Who Have Moderate-To-Severe Arthrofibrosis. J Arthroplasty. 2026 Mar;41(3):862-868. doi: 10.1016/j.arth.2025.07.041. Epub 2025 Jul 24.

    PMID: 40714210BACKGROUND
  • Schneider AM, Rice SJ, Lancaster N, McGraw M, Farid Y, Finn HA. Low-Dose Irradiation and Rotating-Hinge Revision for the Treatment of Severe Idiopathic Arthrofibrosis Following Total Knee Arthroplasty: A Review of 60 Patients With a Mean 6-Year Follow-Up. J Arthroplasty. 2024 Apr;39(4):1075-1082. doi: 10.1016/j.arth.2023.10.021. Epub 2023 Oct 18.

    PMID: 37863275BACKGROUND

Study Officials

  • Jesse Wolfstadt, MD, MSc

    MOUNT SINAI HOSPITAL

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jesse Wolfstadt, MD, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Division Head of Orthopaedic Surgery

Study Record Dates

First Submitted

August 11, 2026

First Posted

August 17, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

January 31, 2029

Last Updated

August 17, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared publicly. De-identified aggregate data supporting the findings of this study will be available upon reasonable request to the corresponding author following publication of primary results.

Locations